Acta Dermato Venereologica · 1981 · 54 citations · 1 references
PharmacyPharmacologyPharmacotherapyBiopharmaceuticsMedical MicrobiologyNecropsy PathologyCombination Antimicrobial TherapyNecrosisCombination Therapy EvaluationDouble-blind TrialsHistological ResponseNecrobiosis LipoidicaNecrotizing InflammationPlacebo Comparators
Fourteen patients with a clinical and histological diagnosis of necrobiosis lipoidica were treated in a double-blind control study with either an aspirin dipyridamole combination or a matching placebo for an 8-week period. None of the patients in the aspirin dipyridamole group showed a significant improvement.
1